We are live on ! Find out more
BLC

Brown, Lisle/Cummings Portfolio holdings

AUM $400M
1-Year Est. Return 18.79%
This Fund
S&P 500
This Quarter Est. Return
+0.35%
1 Year Est. Return
+18.79%
3 Year Est. Return
+61.76%
5 Year Est. Return
10 Year Est. Return
AUM
$335M
AUM Growth
+$5.97M
Cap. Flow
+$10.1M
Cap. Flow %
3%
Top 10 Hldgs %
27.92%
Holding
666
New
47
Increased
170
Reduced
94
Closed
28

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.02M
2
WRB icon
W.R. Berkley
WRB
+$1.01M
3
AMZN icon
Amazon
AMZN
+$842K
4
GD icon
General Dynamics
GD
+$368K
5
NTR icon
Nutrien
NTR
+$344K

Top Sells

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$501K
2
CVS icon
CVS Health
CVS
+$368K
3
BMY icon
Bristol-Myers Squibb
BMY
+$359K
4
PLTR icon
Palantir
PLTR
+$244K
5
FISV
Fiserv Inc
FISV
+$204K

Sector Composition

Rank Sector Weight
1 Technology 17.74%
2 Healthcare 14.93%
3 Financials 13.98%
4 Industrials 10.27%
5 Communication Services 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TD icon
476
Toronto Dominion Bank
TD
$200B
$11.5K ﹤0.01%
216
SHEL icon
477
Shell
SHEL
$245B
$11K ﹤0.01%
175
AWR icon
478
American States Water
AWR
$3.39B
$11K ﹤0.01%
141
PHM icon
479
Pultegroup
PHM
$25.2B
$10.9K ﹤0.01%
100
EZU icon
480
iShare MSCI Eurozone ETF
EZU
$9.9B
$10.6K ﹤0.01%
225
EA
481
DELISTED
Electronic Arts
EA
$10.4K ﹤0.01%
71
EMB icon
482
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
$10.3K ﹤0.01%
116
FTEC icon
483
Fidelity MSCI Information Technology Index ETF
FTEC
$21.2B
$9.98K ﹤0.01%
54
VTRS icon
484
Viatris
VTRS
$19.4B
$9.96K ﹤0.01%
800
-1,079
-57% -$13.3K
IEO icon
485
iShares US Oil & Gas Exploration & Production ETF
IEO
$539M
$9.95K ﹤0.01%
111
XLC icon
486
State Street Communication Services Select Sector SPDR ETF
XLC
$22.3B
$9.68K ﹤0.01%
+100
New +$9.53K
FMS icon
487
Fresenius Medical Care
FMS
$12.9B
$9.49K ﹤0.01%
+419
New +$9.1K
USRT icon
488
iShares Core US REIT ETF
USRT
$4.63B
$9.46K ﹤0.01%
165
ARKG icon
489
ARK Genomic Revolution ETF
ARKG
$1.69B
$9.42K ﹤0.01%
400
+21
+6% +$517
BHRB icon
490
Burke & Herbert Financial Services Corp
BHRB
$1.48B
$9.35K ﹤0.01%
150
ARCB icon
491
ArcBest
ARCB
$3.04B
$9.33K ﹤0.01%
100
HDV
492
iShares Core High Dividend ETF
HDV
$14.8B
$9.32K ﹤0.01%
415
VLO icon
493
Valero Energy
VLO
$84.5B
$9.19K ﹤0.01%
75
ACAD icon
494
Acadia Pharmaceuticals
ACAD
$4.93B
$9.18K ﹤0.01%
500
+250
+100% +$4.04K
FSV icon
495
FirstService
FSV
$6.35B
$9.05K ﹤0.01%
50
GOGL
496
DELISTED
Golden Ocean Group
GOGL
$8.96K ﹤0.01%
1,000
ED icon
497
Consolidated Edison
ED
$39.5B
$8.92K ﹤0.01%
100
SRE icon
498
Sempra
SRE
$55.3B
$8.77K ﹤0.01%
100
GH icon
499
Guardant Health
GH
$22.2B
$8.71K ﹤0.01%
285
EFG icon
500
iShares MSCI EAFE Growth ETF
EFG
$17.2B
$8.42K ﹤0.01%
87

Similar funds

Brown, Lisle/Cummings's Q4 2024 Portfolio in Review

As of Q4 2024, Brown, Lisle/Cummings held 666 positions worth $335M, up 1.8% from $329M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Brown, Lisle/Cummings deployed $10.1M of net new capital in Q4 2024, opening 47 new positions and adding to 170 existing holdings. Its largest new stake was W.R. Berkley: 16,780 shares worth $982K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was T. Rowe Price, an estimated $501K trimmed.

  • Brown, Lisle/Cummings's largest Q4 2024 buy was W.R. Berkley: 16,780 shares worth $982K.
  • Brown, Lisle/Cummings added most to Eli Lilly in Q4 2024, an estimated $1.02M increase.
  • Brown, Lisle/Cummings's biggest Q4 2024 reduction was T. Rowe Price, cutting an estimated $501K.
  • Brown, Lisle/Cummings fully exited TransUnion in Q4 2024, selling an estimated $20.9K.
  • Brown, Lisle/Cummings's ten largest holdings make up 28% of its $335M portfolio in Q4 2024.
  • Brown, Lisle/Cummings opened 47 new positions and closed 28 in Q4 2024.
  • Brown, Lisle/Cummings's portfolio value rose 1.8% quarter-over-quarter to $335M.

Based on Brown, Lisle/Cummings's 13F filing for Q4 2024, filed 27 Jan 2025.